Profilin-3 inhibitors, also known as PFN3 inhibitors, are a class of chemical compounds that interact with the actin cytoskeleton, a dynamic structure crucial for various cellular processes including cell shape, motility, and division. These inhibitors do not target PFN3 directly but rather modulate the actin dynamics in which PFN3 is involved. PFN3, or profilin 3, is a protein that plays a role in the polymerization of actin filaments, which are essential components of the cytoskeleton. By binding to monomeric actin (G-actin), PFN3 helps maintain a pool of actin monomers ready for polymerization into filamentous actin (F-actin). The inhibitors affect the actin dynamics by either stabilizing or destabilizing the actin filaments, sequestering actin monomers, or affecting the proteins that regulate the actin cytoskeleton. These actions can lead to an altered actin turnover rate and a disruption of the finely tuned equilibrium between G-actin and F-actin, thus influencing the activity of PFN3 within the cell.
The chemical compounds classified as PFN3 inhibitors work through various mechanisms to disrupt the normal function of the actin cytoskeleton. Some of these compounds bind directly to actin monomers, preventing them from polymerizing into filaments, while others stabilize the filaments and prevent their disassembly. There are also inhibitors that sever actin filaments, creating new ends that can either be capped or serve as new points for polymerization. Additionally, certain compounds inhibit the nucleating factors that promote the initial assembly of actin monomers into filaments. Another mechanism involves the inhibition of signaling pathways that regulate actin filament assembly and disassembly, or the modulation of motor proteins that generate force for cellular movements. Through these various mechanisms, the inhibitors can alter the dynamics of actin filaments within cells, thereby modulating the environment in which PFN3 operates. While these compounds influence PFN3 activity, their effects are broad and not exclusive to PFN3, impacting other actin-binding proteins and processes within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
Cytochalasin D binds to the barbed ends of actin filaments, blocking polymerization and elongation. This action could possibly inhibit PFN3 by preventing the addition of G-actin to the growing filament ends, which is a process PFN3 facilitates. | ||||||
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $229.00 | 33 | |
Phalloidin binds and stabilizes F-actin, potentially disrupting the dynamic equilibrium of actin polymerization and depolymerization that PFN3 is part of, thus could possibly affect PFN3's role. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $89.00 $262.00 | 13 | |
ML-7 inhibits myosin light chain kinase (MLCK), which affects actin-myosin contraction. This could influence the actin dynamics and cellular processes that PFN3 may be involved in, such as cell motility, which could possibly inhibit PFN3. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $179.00 $307.00 $455.00 $924.00 $1689.00 | 7 | |
Blebbistatin inhibits the ATPase activity of myosin II, affecting actin cytoskeleton dynamics. As PFN3 is involved in actin polymerization, blebbistatin could possibly have an inhibitory effect on PFN3's associated activities. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $88.00 $311.00 | 17 | |
Chelerythrine is a protein kinase C (PKC) inhibitor, which can alter signaling pathways that modulate actin dynamics. As such, it could affect the cellular functions and processes where PFN3 is involved and could possibly inhibit PFN3. | ||||||